ABCD Staging System (Prostata)
Whitmore-Jewett staging system (also known as the Jewett staging system or ABCD system) is a staging system for prostate cancer. It was developed by the American Urological Association (AUA). Most societies (including AUA) and clinicians now advocate and use the TNM staging system.
- A: subclinical tumor: found incidentally (T1 in TNM)
- A1: tissue resembles normal cells; found in a few chips from one lobe
- A2: more extensive involvement
- B: tumor palpable on digital rectal exam (DRE): no extraprostatic extension (T2 in TNM)
- B1: less than 50% one lobe
- B2: more than 50% one lobe
- B3: both lobes
- C: extracapsular extension (T3/T4 in TNM)
- C1: unilateral, not seminal vesicles (T3a)
- C2
- bilateral, not seminal vesicles (T3b)
- seminal vesicles (T3c)
- bladder neck, external anal sphincter, and/or rectum (T4a)
- levator muscles, and/or fixed to pelvic side wall (T4b)
- D: metastasis
- D1: regional adenopathy (N1 in TNM)
- D2: distant metastases (M staging in TNM)
Siehe auch:
Assoziationen und Differentialdiagnosen zu ABCD Staging System (Prostata):